Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Targeted pharmacologic interventions for autism  

This project will examine the efficacy of atomoxetine for hyperactivity associated with autism. This research addresses one of the greatest public health needs in mental health today which is finding safer and more effective medical treatments for autism. This research is also unique in its plan to identify genetic predictors of response to drug treatment in autism.


Funder National Institutes of Health
Fiscal Year Funding $341,475.00
Project Number R01MH077600-02
Principal Investigator Posey, David
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Interventions)
Strategic Plan Objective 4O. Not specific to Question 4 objectives
Federal or Private? Federal
Institution Indiana University-Purdue University Indianapolis
State/Country Indiana
Web Link 1 No URL available.
Web Link 2 No URL available.
Web Link 3 No URL available.
History/Related Projects Targeted pharmacologic interventions for autism | $370,481.00 | 2010 | 5R01MH077600-04
Targeted pharmacologic interventions for autism | $355,516.00 | 2009 | 5R01MH077600-03